Furthermore, ERα expression was also observed in human ovarian cancer MDSCs, and E2-treated non-ovariectomized mice with ovarian cancer showed hastened tumor progression, with decreased levels of helper and cytotoxic T-cells, and increased concentrations of granulocytic MDSCs [174]. The gene discussed is ESR1; the disease is ovarian cancer.